Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Mayo Clinic in Arizona · KU Leuven · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,882
total citations
- FWCI
- 86.19
- Percentile
- 100%
- References
- 18
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Regorafenib
- Medicine
- Placebo
- Clinical endpoint
- Hazard ratio
- Internal medicine
- Interim analysis
- Colorectal cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.